Cannabis produces its effects by plugging into a signaling network your body already runs on its own. Your brain and organs use molecules called endocannabinoids to regulate everything from mood to pain to appetite, and the compounds in cannabis, especially THC, are shaped just well enough to fit the same locks. That molecular mimicry is why a single plant can affect so many seemingly unrelated functions at once, and why the effects range from pleasant to problematic depending on dose, timing, and individual biology.
Your Body’s Built-In Cannabis System
Before anyone ever smokes or eats cannabis, their body is already producing its own cannabinoid-like molecules. The two main ones are anandamide and 2-AG, and together with the receptors they bind to and the enzymes that break them down, they form what researchers call the endocannabinoid system.1PubMed Central. Endocannabinoid signaling and synaptic function This system acts as a kind of dimmer switch for neural activity. When a nerve cell fires too aggressively, the receiving cell releases endocannabinoids backward across the synapse to tell the sender to quiet down. This “retrograde signaling” is the primary way endocannabinoids shape both short-term and long-term changes at synapses throughout the brain.
A 2024 study using optical techniques in live animals confirmed that this retrograde process works on a timescale of seconds during active behavior, suppressing inhibitory signals almost immediately after a neuron fires.2PubMed Central. Retrograde endocannabinoid signaling at inhibitory synapses in vivo That speed matters: it means your endocannabinoid system is constantly fine-tuning neural circuits in real time, adjusting the balance between excitation and inhibition moment to moment. When THC floods those same receptors from the outside, it overrides that careful calibration.
How THC Produces a High
THC, the main psychoactive compound in cannabis, works primarily by binding to CB1 receptors, which are concentrated in brain regions involved in memory, coordination, pleasure, and time perception. Once THC locks onto CB1, it mimics your endocannabinoids but with far more intensity and duration than the brief pulses your body normally sends.
One of the clearest downstream effects is a surge in dopamine. Research in rats showed that intravenous THC produced a dose-dependent increase in the firing rate of dopamine neurons in the brain’s reward pathway, with activity climbing as much as 120 percent above baseline. That dopamine burst was blocked by a CB1 receptor antagonist, confirming it was driven specifically through cannabinoid receptors.3PubMed. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors This dopamine release underlies the euphoria, heightened sensory experience, and reward-seeking behavior that characterize a cannabis high.
How CBD Differs from THC
Cannabidiol, the second most abundant cannabinoid in most cannabis strains, does not produce a high, and the reason comes down to how it interacts with CB1 receptors. Rather than activating them directly the way THC does, CBD acts as a negative allosteric modulator: it binds to a different spot on the receptor and changes the receptor’s shape in a way that makes it harder for other molecules, including THC, to activate it fully.4PubMed Central. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor In practical terms, CBD can dial down some of THC’s effects rather than adding to them. This is part of why high-CBD strains tend to produce a less intense and less anxiety-prone experience compared to strains dominated by THC alone.
CBD also interacts with a range of non-cannabinoid targets in the body, including serotonin receptors and ion channels involved in pain and inflammation. That broader pharmacological profile is what has driven interest in CBD for conditions like epilepsy and anxiety, though the clinical evidence varies widely by condition.
Minor Cannabinoids and the Entourage Effect
Cannabis produces well over a hundred cannabinoids beyond THC and CBD, including CBG, CBN, CBC, and THCV, among others. These so-called minor cannabinoids act on a surprisingly wide range of targets: not just CB1 and CB2 receptors, but also ion channels involved in temperature and pain sensing, receptors tied to fat metabolism, and serotonin receptors.5PubMed Central. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses Most of them are present in tiny amounts, but their collective presence has led to the theory that they matter.
The “entourage effect” is the idea that cannabis compounds work better together than any single compound does alone, with terpenes (the aromatic molecules responsible for the plant’s smell) playing a supporting role.6PubMed Central. The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders Lab research has offered some support: when individual terpenes were combined with a cannabinoid agonist in mice, pain-relief effects increased compared to either compound alone, and the enhancement was selective rather than across the board.7Scientific Reports. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity The entourage effect remains a genuinely interesting hypothesis rather than a settled fact, but it helps explain why users often report that whole-plant products feel different from pure THC isolates.
Why Edibles Hit Differently Than Smoking
The route cannabis enters your body dramatically shapes the experience. When inhaled, THC reaches peak blood levels within about six to ten minutes and has a bioavailability of roughly 10 to 35 percent. When eaten, bioavailability drops to only about 4 to 12 percent, and the onset is much slower because THC has to pass through the digestive tract and liver first.8PubMed Central. Mechanisms of Action and Pharmacokinetics of Cannabis During that liver pass, a significant portion of THC is converted into 11-hydroxy-THC, a metabolite that crosses the blood-brain barrier more readily and may produce stronger psychoactive effects. That conversion is why edibles can feel disproportionately potent despite containing less usable THC overall, and why the delayed onset tempts people into taking a second dose before the first has kicked in.
Memory Disruption
Short-term memory impairment is one of the most consistent and recognizable effects of THC.9PubMed. Biphasic effects of THC in memory and cognition The mechanism has been traced to the hippocampus, a brain region critical for forming new memories. In mice, THC disrupted short-term object-recognition memory through a specific signaling pathway involving protein kinase C (PKC) in hippocampal neurons. Blocking that pathway prevented the short-term memory problem without affecting long-term memory, suggesting THC interferes with a particular step in how new information gets temporarily held rather than corrupting the memory system wholesale.10PubMed Central. Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol The impairment is reversible once THC clears, which is consistent with what most users experience: you struggle to hold a thought while high, but recall functions normally afterward.
The Dose Paradox With Anxiety
Cannabis users often describe the drug as both relaxing and anxiety-inducing, and both descriptions are correct. THC’s effects on anxiety are genuinely biphasic: low doses tend to reduce anxiety, while higher doses can provoke it. Mouse research pinpointed the biology behind this split. At low doses, a cannabinoid agonist produced anti-anxiety effects by acting on CB1 receptors located on glutamate-releasing neurons in the cortex. At high doses, the anxious response was driven by CB1 receptors on GABA-releasing neurons. Knockout mice missing CB1 on one cell type but not the other confirmed this: the calming low-dose effect disappeared only when glutamatergic CB1 receptors were absent, while the anxious high-dose effect disappeared only when GABAergic CB1 receptors were absent.11PubMed Central. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission Follow-up work found that this biphasic pattern was especially pronounced in female rats, with low doses around 0.075 to 0.1 mg/kg reducing anxiety and 1.0 mg/kg increasing it.12PubMed. Female but not male rats show biphasic effects of low doses of Δ(9)-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? The practical lesson is that more THC does not mean more relaxation; at some point the effect flips.
Pain Relief Through Cannabinoid Receptors
Pain is one of the most common reasons people use cannabis medically, and the endocannabinoid system is deeply wired into how your body processes pain signals. Activated cannabinoid receptors raise the threshold for pain detection and suppress the release of inflammatory molecules. They also show synergy with the endogenous opioid system, meaning cannabinoids and opioids can amplify each other’s pain-relieving effects.13PubMed Central. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes Preclinical work has shown reliable pain reduction across inflammatory and neuropathic pain models, and emerging clinical evidence suggests cannabinoid-based medications can relieve pain in conditions like cancer, multiple sclerosis, and fibromyalgia.14Neuropsychopharmacology. The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain The opioid-sparing potential is especially relevant given the risks of long-term opioid use, though cannabinoid analgesics are not a simple substitute.
How Cannabis Affects Appetite
The reputation cannabis has for triggering intense food cravings goes back centuries, and the mechanism is now fairly well understood. THC acts on cannabinoid receptors in brain regions that govern both the desire to eat and the sensory pleasure of food. Users report not just increased hunger but an intensification of taste and smell, making food more rewarding. These effects mirror what your body’s own endocannabinoids do at lower intensity: the endocannabinoid system plays a normal role in regulating appetite, and THC essentially turns the dial up.15PubMed. Cannabinoids and appetite: food craving and food pleasure
Sleep and Dream Suppression
Many people use cannabis to fall asleep, and there is some truth to its sedating properties, but the effect on sleep architecture is more complicated than simply knocking you out. A randomized controlled trial in people with insomnia found that a single dose of THC/CBD significantly reduced REM sleep by about 34 minutes and delayed REM onset by over an hour compared to placebo. Total sleep time actually decreased slightly, by about 25 minutes.16PubMed Central. Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial REM sleep is the stage most closely tied to vivid dreaming and certain types of memory consolidation, which is why heavy cannabis users often report dreamless nights and then vivid, sometimes unsettling dreams when they stop.
Animal research has deepened the picture. A CB1 receptor agonist dramatically restructured sleep stages in rats, lengthening a transitional sleep phase sixfold while suppressing the rhythmic brain activity normally present during REM sleep.17PubMed Central. CB-1 receptor agonist drastically changes oscillatory activity, defining active sleep Those brain rhythms are thought to support memory consolidation, which connects the sleep disruption story back to the memory impairment THC is already known to cause during waking hours.
How Tolerance Develops
Regular cannabis use leads to tolerance, meaning you need more to get the same effect. The mechanism has been directly observed in human brains. PET imaging studies found that daily cannabis smokers had roughly 20 percent fewer available CB1 receptors in cortical and limbic brain regions compared to non-users.18PubMed Central. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers The brain is essentially pulling receptors off the surface in response to the constant flood of THC, reducing its own sensitivity. A separate imaging study found a comparable reduction, about 15 percent lower receptor availability, in cannabis-dependent men.19PubMed Central. Rapid Changes in CB1 Receptor Availability in Cannabis Dependent Males after Abstinence from Cannabis
The encouraging news is that this process reverses. After roughly a month of monitored abstinence, CB1 receptor levels in previously reduced brain regions returned toward normal.18PubMed Central. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers The hippocampus was the one region that lagged behind, which may be relevant to the lingering memory complaints some heavy users report early in abstinence. At the molecular level, a 2025 study identified a specific protein called NEDD4L that drives this tolerance process. Repeated cannabinoid exposure triggers a signaling chain that activates NEDD4L, which tags CB1 receptors for destruction by the cell’s recycling machinery.20PubMed Central. Cannabinoid tolerance relies on CB(1) receptor ubiquitination by NEDD4L
Cardiovascular Effects
Cannabis affects the heart and blood vessels in ways that casual users rarely think about. THC increases heart rate, sometimes significantly, within minutes of use. The available literature describes three main cardiovascular concerns: a condition where blood vessels in the extremities become inflamed (sometimes called cannabis arteritis), vasospasms where arteries temporarily constrict, and changes in platelet behavior that could promote clotting.21PubMed Central. The Cardiovascular Effects of Marijuana: Are the Potential Adverse Effects Worth the High? Whether cannabis accelerates atherosclerosis over time is still unresolved. For most young, healthy users the cardiovascular effects are transient, but people with pre-existing heart conditions face genuine added risk, especially during the first hour after use when heart rate peaks.
Adolescent Brain Vulnerability
The adolescent brain is in the middle of a major pruning and refinement process, particularly in the prefrontal cortex, which handles planning, impulse control, and decision-making. Cannabis use during this window appears to interfere with that process. Brain imaging research in humans found that adolescent cannabis use was associated with cortical thinning, and the pattern matched animal studies in which adolescent rats exposed to THC showed premature pruning of dendritic spines and atrophy of dendritic branches in the prefrontal cortex.22JAMA Psychiatry. Association of Cannabis Use During Adolescence With Neurodevelopment The researchers interpreted the imaging-based thinning and the lab-observed pruning disruption as the same underlying phenomenon. This is one of the more consistent findings in cannabis research and is a major reason public health guidance is particularly cautious about adolescent use.
Genetic Susceptibility to Psychosis
Not everyone who uses cannabis develops psychotic symptoms, and genetics appear to be part of the reason. Research has focused on a gene called AKT1, which is involved in dopamine signaling. One study found that among people who used cannabis daily, those carrying two copies of a particular AKT1 variant (the C/C genotype) had roughly seven times the odds of psychotic disorder compared to daily users carrying the T/T genotype.23PubMed. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users A separate study found the same genotype was linked to slower and less accurate cognitive performance in cannabis-using patients with psychotic disorders.24PubMed Central. AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder
The picture is not perfectly clean, though. A later study looking at acute cannabis intoxication experiences in first-episode psychosis patients, controls, and young adult cannabis users did not find that AKT1 variation modulated the immediate psychotomimetic response to cannabis.25Translational Psychiatry. Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users? The discrepancy may reflect a difference between long-term risk and acute response, or it may mean the genetic story is more complicated than a single gene variant. Either way, the broader finding that some people are biologically more vulnerable to cannabis-related psychosis than others is well supported, even if the precise genetic architecture is still being worked out.
Cannabinoid Hyperemesis Syndrome
One of the stranger adverse effects of chronic cannabis use is cannabinoid hyperemesis syndrome, or CHS, a condition of severe, recurrent vomiting that paradoxically affects heavy users of a plant known for its anti-nausea properties. The leading explanation involves a receptor called TRPV1, which is found in high density in the brain’s chemoreceptor trigger zone for vomiting. Endocannabinoids and exogenous cannabinoids like THC are both agonists of TRPV1, but chronic exposure appears to desensitize the receptor, flipping its effect from anti-emetic to pro-emetic.26PubMed Central. Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin That desensitization may disrupt signaling by substance P, a neuropeptide involved in the vomiting reflex.27PubMed. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment
CHS patients famously find relief in scalding hot showers, a behavior so consistent it is practically a diagnostic clue. The likely reason is that heat itself activates TRPV1 from a different angle, partially compensating for the desensitized chemical signaling. Capsaicin cream applied to the abdomen, another TRPV1 agonist, has also shown benefit for the same reason. The only reliable long-term cure is stopping cannabis use entirely, because the syndrome stems from the accumulated receptor changes that chronic exposure produces.
Why Cannabis Plants Make Cannabinoids at All
From the plant’s perspective, cannabinoids have nothing to do with human brain receptors. Cannabis produces these compounds in glandular trichomes on its flowers and leaves, where they serve a set of ecological survival functions. When trichomes rupture due to heat or an insect biting the plant, the sticky, viscous cannabinoids form a coating that glues shut the mouthparts and legs of herbivores. Cannabinoids also absorb UV-B radiation, functioning as a biochemical sunscreen; studies have measured increased cannabinoid production after UV-B stress.28Trends in Plant Science. How Cannabis Works: The Science Behind Its Effects The genes responsible for producing THC, CBD, and CBC all trace back to a single ancestral gene that is unique to the Cannabis lineage, meaning no other plant genus shares these particular biosynthetic enzymes.29Genome Biology and Evolution. Origin and Evolution of the Cannabinoid Oxidocyclase Gene Family The fact that these molecules happen to fit human neural receptors is an evolutionary accident, albeit one that has profoundly shaped human culture.